Inogen, Inc. INGN 深 滬
已收盤 02-06 16:00:00 美东时间
5.66
0.000
0.00%
華盛通- 最 高5.775
- 今 開5.71
- 成交量 33.73万股
- 最 低 5.62
- 昨 收 5.66
- 總市值 1.54亿
- 52周最高 11.94
- 市盈率 靜 --
- 換手率 1.24%
- 52周最低 5.62
- 委 比 -95.98%
- 總股本 2714.85万
- 歷史最高 287.79
- 量 比 1.78
- 振 幅 2.74%
- 歷史最低 4.13
- 每 手 1
- 風險率 1.08%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Inogen Estimates Preliminary Total Revenue In Q4 To Be ~$82M, Up ~2% YoY; Expects FY25 Preliminary Revenue To Be ~$349M, Up ~4% YoY
Inogen to Announce Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026Inogen, Inc. (NASDAQ:INGN), a medical technology company offering innovative respiratory products for use in the homecare
01-12 21:38
Inogen Lowers Q4 Sales Guidance from $87.000M-$90.000M to $82.000M vs $88.600M Est
Inogen (NASDAQ:INGN) lowers Q4 sales outlook from $87.000 million-$90.000 million to $82.000 million vs $88.600 million estimate.
01-12 21:34
Inogen Lowers FY2025 Sales Guidance from $354.000M-$357.000M to $349.000M vs $355.600M Est
Inogen (NASDAQ:INGN) lowers FY2025 sales outlook from $354.000 million-$357.000 million to $349.000 million vs $355.600 million estimate.
01-12 21:34
Inogen shares are trading higher after the company launched its Aurora CPAP masks in the US.
Inogen shares are trading higher after the company launched its Aurora CPAP mas...
01-07 21:33
Inogen Sees Q3 Sales $91.000M-$93.000M vs $93.267M Est
Inogen (NASDAQ:INGN) sees Q3 sales of $91.000 million-$93.000 million vs $93.267 million analyst estimate.
2025-08-08 04:29
美股大行评级 | 潜在涨幅40%！华兴资本首予Coinbase买入评级，目标价353.3！Sarepta治疗遭多家机构下调评级和目标价！
美股大行评级 | 潜在涨幅40%！华兴资本首予Coinbase买入评级，目标价353.3！Sarepta治疗遭多家机构下调评级和目标价！
2025-06-18 09:46
美股大行评级 | 超配！Hinge Health获多家大行首予评级； Oppenheimer上调Mate目标价从665美元升至775美元
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1141651881139785729.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• Ascendiant Capital：维持SurgePays Inc(SURG)"买入"评级，目标价从8.75美元升至9美元</p> <p>• Ascendiant Capital：维持LiqTech Internatio
2025-06-17 09:46
B. Riley Securities Initiates Coverage On Inogen with Buy Rating, Announces Price Target of $14
B. Riley Securities analyst Anderson Schock initiates coverage on Inogen (NASDAQ:INGN) with a Buy rating and announces Price Target of $14.
2025-06-17 01:31
美股大行评级 | 高盛上调微软目标价从480美元至550美元，Snowflake获多家机构上调目标价！
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1132593314765758464.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• 摩根大通：维持IDEAYA Biosciences(IDYA)"超配"评级，目标价从63美元升至66美元</p> <p>• Needham：上调Inogen(INGN)评级至"买入"，目标价12美元</p> <p>• E
2025-05-23 11:19
Inogen Upgraded: Analyst Sees Growth, EBITDA Breakthrough
Needham's Mike Matson upgrades Inogen to Buy, citing turnaround progress, margin gains, and path to EBITDA breakeven by 2025.
2025-05-23 01:38
